EN / ES
Colombia Regenerative Cells / Clínica Nieves

Scaling the future of Regenerative Medicine

We're building exosome and MSC-based cellular therapies with GMP-ready infrastructure for Latin America and global export.

Meet in Dublin Learn our story
Q3 '26
Protocol completion
Q1 '27
Pilot studies start
15 min
Coffee in Dublin
The story — why we exist

A region with clinical need and zero local access to cellular therapies.

Latin America imports 100% of its advanced therapies at prohibitive costs. We're building the region's first GMP-capable cellular therapy hub so patients stop waiting for access that never comes.

Current phase — where we are today
In progress: Preclinical Validation and GMP Facility Design

Completing technical validation of exosome and MSC production

Finalizing characterization profiles (size, potency, purity) and mapping our GMP facility under international export standards.

Technical validation 72% complete
The Roadmap — where we're going

The Roadmap

Now

Preclinical validation and facility design

Exosome/MSC characterization + GMP plant design under international standards

In progress
Q3 2026

Production protocol completion

Finalization of exosome and MSC manufacturing protocols; complete SOP documentation

Next milestone
Q1 2027

Safety studies and pilot trials initiation

First safety/efficacy data in vivo; partnerships with regional clinical centers

Planned
2028+

Leading LatAm cellular therapy HUB — export standard

Become the regional reference GMP hub with international export capacity

Final goal
Contact us

Let's talk in Dublin

15 minutes over coffee — tell us what you're looking for, we'll show you how we fit.

We'll respond within 24 hours